576 related articles for article (PubMed ID: 18396333)
1. Targeted delivery of paclitaxel using folate-decorated poly(lactide)-vitamin E TPGS nanoparticles.
Pan J; Feng SS
Biomaterials; 2008 Jun; 29(17):2663-72. PubMed ID: 18396333
[TBL] [Abstract][Full Text] [Related]
2. Folate-decorated hybrid polymeric nanoparticles for chemically and physically combined paclitaxel loading and targeted delivery.
Wang J; Liu W; Tu Q; Wang J; Song N; Zhang Y; Nie N; Wang J
Biomacromolecules; 2011 Jan; 12(1):228-34. PubMed ID: 21158381
[TBL] [Abstract][Full Text] [Related]
3. Nanoparticles of poly(lactide)/vitamin E TPGS copolymer for cancer chemotherapy: synthesis, formulation, characterization and in vitro drug release.
Zhang Z; Feng SS
Biomaterials; 2006 Jan; 27(2):262-70. PubMed ID: 16024075
[TBL] [Abstract][Full Text] [Related]
4. The drug encapsulation efficiency, in vitro drug release, cellular uptake and cytotoxicity of paclitaxel-loaded poly(lactide)-tocopheryl polyethylene glycol succinate nanoparticles.
Zhang Z; Feng SS
Biomaterials; 2006 Jul; 27(21):4025-33. PubMed ID: 16564085
[TBL] [Abstract][Full Text] [Related]
5. Targeting and imaging cancer cells by folate-decorated, quantum dots (QDs)- loaded nanoparticles of biodegradable polymers.
Pan J; Feng SS
Biomaterials; 2009 Feb; 30(6):1176-83. PubMed ID: 19062089
[TBL] [Abstract][Full Text] [Related]
6. Folate-decorated poly(lactide-co-glycolide)-vitamin E TPGS nanoparticles for targeted drug delivery.
Zhang Z; Huey Lee S; Feng SS
Biomaterials; 2007 Apr; 28(10):1889-99. PubMed ID: 17197019
[TBL] [Abstract][Full Text] [Related]
7. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
Feng SS; Mei L; Anitha P; Gan CW; Zhou W
Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
[TBL] [Abstract][Full Text] [Related]
8. Formulation, characterization, and in vitro evaluation of quantum dots loaded in poly(lactide)-vitamin E TPGS nanoparticles for cellular and molecular imaging.
Pan J; Wang Y; Feng SS
Biotechnol Bioeng; 2008 Oct; 101(3):622-33. PubMed ID: 18727131
[TBL] [Abstract][Full Text] [Related]
9. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance.
Liu Y; Pan J; Feng SS
Int J Pharm; 2010 Aug; 395(1-2):243-50. PubMed ID: 20472049
[TBL] [Abstract][Full Text] [Related]
10. Docetaxel-loaded nanoparticles based on star-shaped mannitol-core PLGA-TPGS diblock copolymer for breast cancer therapy.
Tao W; Zeng X; Liu T; Wang Z; Xiong Q; Ouyang C; Huang L; Mei L
Acta Biomater; 2013 Nov; 9(11):8910-20. PubMed ID: 23816645
[TBL] [Abstract][Full Text] [Related]
11. Self-assembled nanoparticles of poly(lactide)--Vitamin E TPGS copolymers for oral chemotherapy.
Zhang Z; Feng SS
Int J Pharm; 2006 Nov; 324(2):191-8. PubMed ID: 16842944
[TBL] [Abstract][Full Text] [Related]
12. Nanoparticles of star-like copolymer mannitol-functionalized poly(lactide)-vitamin E TPGS for delivery of paclitaxel to prostate cancer cells.
Wang K; Guo L; Xiong W; Sun L; Zheng Y
J Biomater Appl; 2014 Sep; 29(3):329-40. PubMed ID: 24621530
[TBL] [Abstract][Full Text] [Related]
13. A novel controlled release formulation for the anticancer drug paclitaxel (Taxol): PLGA nanoparticles containing vitamin E TPGS.
Mu L; Feng SS
J Control Release; 2003 Jan; 86(1):33-48. PubMed ID: 12490371
[TBL] [Abstract][Full Text] [Related]
14. Nanoparticles of biodegradable polymers for clinical administration of paclitaxel.
Feng SS; Mu L; Win KY; Huang G
Curr Med Chem; 2004 Feb; 11(4):413-24. PubMed ID: 14965222
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo evaluation of methoxy polyethylene glycol-polylactide (MPEG-PLA) nanoparticles for small-molecule drug chemotherapy.
Dong Y; Feng SS
Biomaterials; 2007 Oct; 28(28):4154-60. PubMed ID: 17576004
[TBL] [Abstract][Full Text] [Related]
16. Enhanced oral bioavailability of paclitaxel formulated in vitamin E-TPGS emulsified nanoparticles of biodegradable polymers: in vitro and in vivo studies.
Zhao L; Feng SS
J Pharm Sci; 2010 Aug; 99(8):3552-60. PubMed ID: 20564384
[TBL] [Abstract][Full Text] [Related]
17. Novel Soluplus(®)-TPGS mixed micelles for encapsulation of paclitaxel with enhanced in vitro cytotoxicity on breast and ovarian cancer cell lines.
Bernabeu E; Gonzalez L; Cagel M; Gergic EP; Moretton MA; Chiappetta DA
Colloids Surf B Biointerfaces; 2016 Apr; 140():403-411. PubMed ID: 26780253
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo studies on vitamin E TPGS-emulsified poly(D,L-lactic-co-glycolic acid) nanoparticles for paclitaxel formulation.
Win KY; Feng SS
Biomaterials; 2006 Apr; 27(10):2285-91. PubMed ID: 16313953
[TBL] [Abstract][Full Text] [Related]
19. Enhanced toxicity and cellular uptake of methotrexate-conjugated nanoparticles in folate receptor-positive cancer cells by decorating with folic acid-conjugated d-α-tocopheryl polyethylene glycol 1000 succinate.
Junyaprasert VB; Dhanahiranpruk S; Suksiriworapong J; Sripha K; Moongkarndi P
Colloids Surf B Biointerfaces; 2015 Dec; 136():383-93. PubMed ID: 26433645
[TBL] [Abstract][Full Text] [Related]
20. Paclitaxel-loaded PCL-TPGS nanoparticles: in vitro and in vivo performance compared with Abraxane®.
Bernabeu E; Helguera G; Legaspi MJ; Gonzalez L; Hocht C; Taira C; Chiappetta DA
Colloids Surf B Biointerfaces; 2014 Jan; 113():43-50. PubMed ID: 24060929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
